Evidence map›Paper›PMID 31703715›Full record

ArticleBMC oral health2019

Predictive factors related to the progression of periodontal disease in patients with early rheumatoid arthritis: a cohort study.

Ana María Heredia-P, Gloria Inés Lafaurie, Wilson Bautista-Molano, Tamy Goretty Trujillo, Philippe Chalem-Choueka, Juan M Bello-Gualtero, Cesar Pacheco-Tena, Lorena Chila-Moreno, Consuelo Romero-Sánchez

Open access · goldAbstract read
In one paragraph

Article in BMC oral health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Periodontal Disease in Diabetes Mellitus: A Case-Control Study in Smokers and Non-Smokers.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ana María Heredia-PUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogotá, Colombia.
Gloria Inés LafaurieUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogotá, Colombia.
Wilson Bautista-MolanoClinical Immunology Group, Rheumatology and Immunology Department Hospital Militar Central/School of Medicine, Universidad Militar Nueva Granada, Transversal 3ª #, 49-00, Bogotá, Colombia.
Tamy Goretty TrujilloUnit of Basic Oral Investigation-UIBO, School of Dentistry, Universidad El Bosque, Bogotá, Colombia.
Philippe Chalem-ChouekaFundación Instituto de Reumatología Fernando Chalem, Bogotá, Colombia.
Juan M Bello-GualteroClinical Immunology Group, Rheumatology and Immunology Department Hospital Militar Central/School of Medicine, Universidad Militar Nueva Granada, Transversal 3ª #, 49-00, Bogotá, Colombia.
Cesar Pacheco-TenaInvestigación y Biomedicina de Chihuahua SC, Chihuahua, Mexico.
Lorena Chila-MorenoCellular and Molecular Immunology Group/ INMUBO, School of Dentistry, Universidad El Bosque, Cra 9 No. 131 A-02, Bogotá, Colombia.
Consuelo Romero-SánchezClinical Immunology Group, Rheumatology and Immunology Department Hospital Militar Central/School of Medicine, Universidad Militar Nueva Granada, Transversal 3ª #, 49-00, Bogotá, Colombia. romeromaria@unbosque.edu.co.ORCID 0000-0002-6973-7639
Universidad El Bosque · COAutonomous University of Chihuahua · MXFundacion Instituto de Reumatologia Fernando Chalem · COMilitary University Nueva Granada · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRheumatoid arthritis (RA) and periodontal disease are inter-related conditions. However, factors predictive of periodontal disease progression in patients with early rheumatoid arthritis (eRA) are lacking. The aim of this study was to identify factors associated with the progression of clinical attachment loss (CAL) in interproximal dental sites of eRA patients.

methodsTwenty-eight eRA patients were evaluated for the progression of CAL at 280 interproximal dental sites at 1 year of follow-up. Markers of RA activity (rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein), a marker of bone resorption (Dickkopf-related protein 1), Disease Activity Score 28 and Simple Disease Activity Index were included as potential systemic predictive factors. Plaque index, gingival index, pocket depth, clinical attachment level and Dickkopf-related protein 1 in crevicular fluid at baseline were included as potential local predictive factors. Data were analysed in a hierarchical structure using generalised linear mixed models for progression at each site (> 2 mm) during follow-up.

resultsC-reactive protein level was the most important predictive systemic factor for the progression of CAL. The mean CAL and a high degree of gingival inflammation in interproximal sites at baseline were important predictive local factors (p <  0.0001). Patients who received combined treatment with disease-modifying antirheumatic drugs and corticosteroids exhibited less CAL (p <  0.0001). The predictive value of the generalised linear mixed model for progression was 85%.

conclusionsSystemic factors, including RA disease activity and baseline periodontal condition, were associated with periodontal progression. Pharmacological treatment may affect periodontal progression in patients with early RA.

Indexed as

Antirheumatic AgentsArthritis, RheumatoidPeriodontal DiseasesCohort StudiesDisease ProgressionFemaleHumansMalePeriodontal Attachment LossAntirheumatic AgentsC-reactive proteinDAS28Dickkopf-related protein 1Early rheumatoid arthritisPeriodontitis

Identifiers

PMID31703715
PMCPMC6842164
OpenAlexW2985093040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.